RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:SHFM1 deficiency suppresses esophageal squamous cell carcinomas progression via modulating NF‑κB signaling and enhancing nature killer cell‑mediated tumor surveillance.
SHFM1 deficiency suppresses esophageal squamous cell carcinomas progression via modulating NF‑κB signaling and enhancing nature killer cell‑mediated tumor surveillance.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
过度增殖、转移和免疫逃逸是推动肿瘤进展的重要特征。裂手裂足畸形1(SHFM1)在多种癌症中过表达,并被报道可增强恶性表型,但其在食管鳞状细胞癌(ESCC)中的作用尚未明确。研究者整合生物信息学分析GSE芯片数据筛选ESCC进展候选基因,发现SHFM1在ESCC组织中较正常组织显著上调,且高表达与预后较差相关。随后在体外敲低或过表达SHFM1,评估细胞生长、转移和免疫逃逸;并以异种移植小鼠研究体内肿瘤进展。SHFM1过表达促进ESCC细胞体外增殖和迁移及体内成瘤,敲低则逆转上述表型。其恶性作用伴随NF-κB通路活化、P65磷酸化和核转位增加。SHFM1还调节癌细胞对NK细胞的敏感性;抑制SHFM1增强细胞介导的凋亡及NK细胞毒性,可能涉及c-Myc和PD-L1下调。综上,SHFM1可能通过激活NF-κB并增强ESCC细胞抵抗NK杀伤而促进肿瘤进展,是潜在治疗靶点。
Excessive proliferation, metastasis and immune escape are considered to be hallmarks of cancer contributing to tumor progression. Split hand and foot malformation 1 (SHFM1) is highly expressed in various cancers and has been reported to increase malignant behaviors.
However, the biological functions of SHFM1 in esophageal squamous cell carcinomas (ESCC) progression remain to be elucidated. An integrated bioinformatics analysis was performed to identify candidate genes in ESCC progression based on GSE microarrays. SHFM1 was found to be profoundly upregulated in ESCC tissues compared with normal tissues and SHFM1 expression was positively associated with poor prognosis.
The biological effects of SHFM1 on cell growth, metastasis and immune escape were investigated following depletion or overexpression of SHFM1 in vitro . A xenograft mouse model was established to investigate the effect of SHFM1 on ESCC progression in vivo . SHFM1 overexpression promoted ESCC cell proliferation and migration in vitro as well as tumorigenesis in vivo , while SHFM1 knockdown restored those phenotype changes.
Additionally, the present study demonstrated that the effects of SHFM1 on malignant behaviors of ESCC cells were achieved by activating the NF- B signaling accompanied by increased P65 phosphorylation and nuclear translocation.
Furthermore, SHFM1 was also found to regulate the sensitivity of cancer cells to natural killer (NK) cells. Specifically, inhibition of SHFM1 enhanced cell-mediated cell apoptosis and increased NK toxicity, which might involve the downregulation of c-Myc and programmed death-ligand 1, key targets in cancer immunotherapy.
In conclusion, these findings suggested that SHFM1 probably promoted ESCC progression by activating the NF- B pathway and enhancing the resistance of ESCC cells to NK cell cytotoxicity, indicating that SHFM1 may be a promising target for ESCC treatment.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。